Enzo Biochem (ENZ) News Today $0.76 +0.05 (+7.05%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Enzo Biochem, Inc. Reports Fiscal Q1 2024 Financial Results and Declares Special Cash DividendDecember 18 at 11:16 PM | nasdaq.comEnzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024)December 18 at 6:15 PM | finance.yahoo.comStockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)StockNews.com started coverage on shares of Enzo Biochem in a report on Tuesday. They set a "hold" rating on the stock.December 17, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Announces Quarterly Earnings ResultsEnzo Biochem (NYSE:ENZ - Get Free Report) issued its quarterly earnings data on Monday. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.December 16, 2024 | marketbeat.comEnzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company UpdateDecember 16, 2024 | globenewswire.comStockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)StockNews.com began coverage on shares of Enzo Biochem in a report on Monday. They issued a "hold" rating for the company.December 9, 2024 | marketbeat.comThe Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo BiochemDecember 5, 2024 | uk.finance.yahoo.comTop Stock Reports for Amgen, Eaton & Enzo BiochemDecember 5, 2024 | msn.comEnzo Biochem, Inc. (NYSE:ENZ) Short Interest Down 9.3% in NovemberEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 433,000 shares, a drop of 9.3% from the October 31st total of 477,500 shares. Based on an average daily volume of 86,700 shares, the days-to-cover ratio is currently 5.0 days. Currently, 1.2% of the company's stock are sold short.December 2, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on shares of Enzo Biochem in a research note on Sunday. They set a "hold" rating for the company.December 1, 2024 | marketbeat.comEnzo Biochem Appoints Jon Couchman to BoardNovember 26, 2024 | markets.businessinsider.comEnzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.comStockNews.com began coverage on shares of Enzo Biochem in a research note on Saturday. They issued a "hold" rating on the stock.November 23, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Now Covered by StockNews.comStockNews.com began coverage on Enzo Biochem in a research note on Friday. They set a "hold" rating for the company.November 15, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock, Option ChainNovember 11, 2024 | benzinga.comEnzo Biochem, Inc.: Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendNovember 4, 2024 | finanznachrichten.deEnzo Biochem Reports Revenue Growth Despite LossesOctober 31, 2024 | markets.businessinsider.comEnzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023)October 31, 2024 | finance.yahoo.comWe're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn RateOctober 31, 2024 | finance.yahoo.comEnzo Biochem (NYSE:ENZ) Stock Price Passes Above 200 Day Moving Average - Should You Sell?Enzo Biochem (NYSE:ENZ) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?October 30, 2024 | marketbeat.comEnzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendOctober 29, 2024 | globenewswire.comEnzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.comStockNews.com started coverage on Enzo Biochem in a research report on Tuesday. They issued a "hold" rating on the stock.October 22, 2024 | marketbeat.comEnzo Biochem, Inc. (NYSE:ENZ) Sees Significant Increase in Short InterestEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 518,000 shares, a growth of 8.2% from the September 15th total of 478,700 shares. Approximately 1.4% of the shares of the stock are short sold. Based on an average daily volume of 74,600 shares, the days-to-cover ratio is currently 6.9 days.October 17, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comEnzo Biochem (NYSE:ENZ) Shares Pass Above 200-Day Moving Average of $1.13Enzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.13September 28, 2024 | marketbeat.comRecombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6% - SNS InsiderSeptember 25, 2024 | finance.yahoo.comWorried About Financial Fraud After A Healthcare Data Breach? Here's What You Can DoSeptember 25, 2024 | forbes.comConnecticut Attorney General announces $1.7 million false claims settlement with Enzo Clinical LabsSeptember 21, 2024 | msn.comEnzo Biochem Inc (EZB.DU)September 20, 2024 | ca.finance.yahoo.comEnzo Biochem (NYSE:ENZ) Share Price Crosses Above 200-Day Moving Average of $1.14Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above 200-Day Moving Average of $1.14September 20, 2024 | marketbeat.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 10.0%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 531,800 shares, a decline of 10.0% from the July 15th total of 591,200 shares. Based on an average trading volume of 119,600 shares, the short-interest ratio is presently 4.4 days. Currently, 1.5% of the shares of the stock are sold short.August 18, 2024 | marketbeat.comUnicoin hints at potential data meddling after G-Suite compromiseAugust 16, 2024 | msn.comBiotech company settles for $4.5M after cybercriminals use decade-old password in massive data breach: NY AGAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5m for leaked healthcare data due to lax securityAugust 14, 2024 | finance.yahoo.comEnzo Biochem ordered to cough up $4.5 million over lousy security that led to ransomware disasterAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5 million over cyberattack, NY attorney general saysAugust 14, 2024 | msn.comEnzo Biochem to Pay $4.5 Million for Failing to Safeguard Patient DataAugust 14, 2024 | usnews.comParamount laying off another 15 percent of its US workforceAugust 14, 2024 | sg.news.yahoo.com10-year-old passwords helped hackers get company’s customer info, AG saysAugust 14, 2024 | nj.comEnzo Biochem penalized $4.5M over data breachAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5 mln for failing to safeguard patient dataAugust 13, 2024 | reuters.comRare Stock Picks In July 2024 - From 29 Discerning AnalystsAugust 6, 2024 | seekingalpha.comENZ Enzo Biochem, Inc.July 25, 2024 | seekingalpha.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Expands By 8.0%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 605,300 shares, an increase of 8.0% from the June 15th total of 560,500 shares. Approximately 1.7% of the shares of the stock are short sold. Based on an average daily volume of 132,100 shares, the short-interest ratio is presently 4.6 days.July 18, 2024 | marketbeat.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 6.9%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 560,500 shares, a drop of 6.9% from the May 31st total of 602,300 shares. Currently, 1.6% of the shares of the stock are sold short. Based on an average daily volume of 114,700 shares, the days-to-cover ratio is presently 4.9 days.July 3, 2024 | marketbeat.comENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024June 14, 2024 | investorplace.comEnzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateJune 13, 2024 | globenewswire.comEnzo Biochem, Inc. (ENZ)May 19, 2024 | finance.yahoo.comIn Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarketsMarch 28, 2024 | finanznachrichten.deEnzo Biochem, Inc. (NYSE:ENZ) Sees Large Decrease in Short InterestEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 29th, there was short interest totalling 715,400 shares, a decrease of 9.8% from the February 14th total of 792,900 shares. Approximately 2.1% of the company's shares are sold short. Based on an average daily trading volume, of 113,500 shares, the short-interest ratio is presently 6.3 days.March 18, 2024 | marketbeat.comEnzo Biochem, Inc.: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateMarch 14, 2024 | finanznachrichten.de Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. ENZ Media Mentions By Week ENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZ News Sentiment▼-0.350.60▲Average Medical News Sentiment ENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZ Articles This Week▼61▲ENZ Articles Average Week Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biodesix News Today EUDA Health News Today Quipt Home Medical News Today Exagen News Today Burning Rock Biotech News Today P3 Health Partners News Today Concord Medical Services News Today Oncology Institute News Today Psychemedics News Today Marpai News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENZ) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZ Stock Alerts